Julia Pickel

Julia Pickel

Auto-generated profile, based on publicly available information

Julia Pickel

Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; PolicyLab, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Journal of Adolescent Health
Verified
Journal Article
Closed access
SWSarah M. Wood
Sarah M. Wood
KWKrishna White
Krishna White
RPRebecka Peebles
Rebecka Peebles
JPJulia Pickel
Julia Pickel
MAMaryam Alausa
Maryam Alausa
NDNadia Dowshen
Nadia Dowshen

1 August 2019 in Ophthalmology
Verified
Journal Article
Closed access
SNShivananda Narayana
Shivananda Narayana
TKTiruvengada Krishnan
Tiruvengada Krishnan
SRSeema Ramakrishnan
Seema Ramakrishnan
PSPuja Prativa Samantaray
Puja Prativa Samantaray
AAAriana Austin
Ariana Austin
JRJennifer R. Rose-Nussbaumer
Jennifer R. Rose-Nussbaumer

15 November 2021 in JMIR Pediatrics and Parenting
Verified
Journal Article
Open access
SWSarah M Wood
Sarah M Wood
JPJulia Pickel
Julia Pickel
APAlexis W Phillips
Alexis W Phillips
KBKari Baber
Kari Baber
JCJohn Chuo
John Chuo
LSLisa A Schwartz
Lisa A Schwartz
Background: Data regarding the acceptability, feasibility, and quality of telehealth among adolescents and young adults (AYA) and their parents and caregivers (caregivers) are lacking. Objective: The aim of this study was to assess the noninferiority of telehealth versus in-person visits by comparing acceptability with respect to efficiency, effectiveness, equity, patient-centeredness, and confidentiality. Methods: Cross-sectional web-based surveys were sent to caregivers and AYA following video visits within an Adolescent Medicine subspecialty clinic in May-July 2020. Proportions of AYA and caregivers who rated telehealth as noninferior were compared using chi-squared tests. Feasibility was assessed via items measuring technical difficulties. Deductive thematic analysis using the Institute of Medicine dimensions of health care quality was used to code open-ended question responses. Results: Survey response rates were 20.5% (55/268) for AYA and 21.8% (123/563) for caregivers. The majority of the respondents were White cisgender females. Most AYA and caregivers rated telehealth as noninferior to in-person visits with respect to confidentiality, communication, medication management, and mental health care. A higher proportion of AYA compared to caregivers found telehealth inferior with respect to confidentiality (11/51, 22% vs 3/118, 2.5%, P<.001). One-quarter (14/55) of the AYA patients and 31.7% (39/123) of the caregivers reported technical difficulties. The dominant themes in the qualitative data included advantages of telehealth for efficiency and equity of health care delivery. However, respondents’ concerns included reduced safety and effectiveness of care, particularly for patients with eating disorders, owing to lack of hands-on examinations, collection of vital signs, and laboratory testing. Conclusions: Telehealth was highly acceptable among AYA and caregivers. Future optimization should include improving privacy, ameliorating technical difficulties, and standardizing at-home methods of obtaining patient data to assure patient safety.

1 July 2019 in JAMA Ophthalmology
Verified
Journal Article
Open access
PDF file
MAMichael J. Ang
Michael J. Ang
WCWinston Chamberlain
Winston Chamberlain
CLCharles C. Lin
Charles C. Lin
JPJulia Pickel
Julia Pickel
AAAriana Austin
Ariana Austin
JRJennifer R. Rose-Nussbaumer
Jennifer R. Rose-Nussbaumer
Importance Vision-related quality of life can be a valuable outcome for some interventions in ophthalmology. In the primary Descemet Endothelial Thickness Comparison Trial (DETECT), Descemet membrane endothelial keratoplasty (DMEK) had superior postoperative visual acuity compared with ultrathin Descemet stripping automated endothelial keratoplasty (UT-DSAEK). It is of interest to determine whether this trend extends to quality of life. Objective To determine the effect of UT-DSAEK and DMEK on vision-related quality of life. Design, Setting, and Participants A prespecified secondary analysis of a 2-surgeon patient- and outcome-masked randomized clinical trial was conducted at the Casey Eye Institute in Portland, Oregon, and Byers Eye Institute in Palo Alto, California. The study was conducted between January 20, 2015, and April 26, 2017. DETECT enrolled 38 individuals and included 50 eyes with isolated endothelial dysfunction; for this analysis, the second eye from a single participant was excluded along with any questionnaires in the first eye after second eye surgery for evaluation of 38 eyes at baseline and 3 months and 26 eyes at 12 months. Mean (SD) baseline visual acuity was 0.35 (0.31) logMAR in the DMEK arm and 0.28 (0.22) logMAR in the UT-DSAEK arm. Each arm consisted of 19 participants: 18 individuals with Fuchs dystrophy and 1 participant with pseudophakic bullous keratopathy. Interventions Study eyes were randomized to receive either UT-DSAEK or DMEK. Main Outcomes and Measures Responses to the National Eye Institute (NEI) Visual Function Questionnaire-39 (VFQ-39) administered at baseline and 3 and 12 months postoperatively were analyzed using the NEI-defined traditional subscales and composite score on a 100-point scale and with a Rasch-refined analysis. Results There were more women in both arms of the study (UT-DSAEK, 12 [63%]; DMEK, 11 [58%]); mean (SD) age was 68 (11) years in the UT-DSAEK arm and 68 (4) years in the DMEK arm. Overall, study participants experienced a 9.1-point improvement in NEI VFQ-39 composite score at 3 months compared with baseline (N = 38; 95% CI, 4.9-13.3;P < .001), and an 11.6-point improvement at 12 months compared with baseline (n = 26; 95% CI, 6.8-16.4;P < .001). Eyes randomized to DMEK had 0.9 points more improvement in NEI VFQ-39 composite score at 3 months compared with UT-DSAEK after controlling for baseline NEI VFQ-39 (95% CI, −6.2 to 8.0;P = .80). Conclusions and Relevance Improvement in vision-related quality of life was not shown to be greater with DMEK compared with UT-DSAEK. Trial Registration ClinicalTrials.gov identifier:NCT02373137

22 February 2022 in Journal of the International AIDS Society
Verified
Journal Article
Open access
DWDovie L. Watson
Dovie L. Watson
PSPamela A. Shaw
Pamela A. Shaw
DPDanielle T. Petsis
Danielle T. Petsis
JPJulia Pickel
Julia Pickel
JBJosé A. Bauermeister
José A. Bauermeister
RGRobert Gross
Robert Gross
Introduction: Youth account for a disproportionate number of new HIV infections; however, pre‐exposure prophylaxis (PrEP) use is limited. We evaluated PrEP counselling rates among non‐Hispanic Black youth in the United States after a bacterial sexually transmitted infection (STI) diagnosis.Methods: We conducted a retrospective cohort study of Black youth receiving care at two academically affiliated clinics in Philadelphia between June 2014 and June 2019. We compared PrEP counselling for youth who received primary care services versus those who did not receive primary care services, all of whom met PrEP eligibility criteria due to STI diagnosis per U.S. Centers for Disease Control and Prevention clinical practice guidelines. Two logistic regression models for receipt of PrEP counselling were fit: Model 1 focused on sexual and gender minority (SGM) status and Model 2 on rectal STIs with both models adjusted for patient‐ and healthcare‐level factors.Results: Four hundred and sixteen patients met PrEP eligibility criteria due to STI based on sex assigned at birth and sexual partners. Thirty patients (7%) had documentation of PrEP counselling. Receipt of primary care services was not significantly associated with receipt of PrEP counselling in either Model 1 (adjusted OR (aOR) 0.10 [95% CI 0.01, 0.99]) or Model 2 (aOR 0.52 [95% CI 0.10, 2.77]). Receipt of PrEP counselling was significantly associated with later calendar years of STI diagnosis (aOR 6.80 [95% CI 1.64, 29.3]), assigned male sex at birth (aOR 26.2 [95% CI 3.46, 198]) and SGM identity (aOR 317 [95% CI 39.9, 2521]) in Model 1 and later calendar years of diagnosis (aOR 3.46 [95% CI 1.25, 9.58]), assigned male sex at birth (aOR 18.6 [95% CI 3.88, 89.3]) and rectal STI diagnosis (aOR 28.0 [95% CI 8.07, 97.5]) in Model 2. Fourteen patients (3%) started PrEP during the observation period; 12/14 (86%) were SGM primary care patients assigned male sex at birth.Conclusions: PrEP counselling and uptake among U.S. non‐Hispanic Black youth remain disproportionately low despite recent STI diagnosis. These findings support the need for robust investment in PrEP‐inclusive sexual health services that are widely implemented and culturally tailored to Black youth, particularly cisgender heterosexual females.

1 July 2020 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
JPJulia Pickel
Julia Pickel
SNShivananda Narayana
Shivananda Narayana
TKTiruvengada Krishnan
Tiruvengada Krishnan
SRSeema Ramakrishnan
Seema Ramakrishnan
PSPuja Prativa Samantaray
Puja Prativa Samantaray
JRJennifer R. Rose-Nussbaumer
Jennifer R. Rose-Nussbaumer